Evidence map›Paper›PMID 29568285›Full record

ArticleFrontiers in microbiology2018

Vinod Kumar, Ajay Kumar, Sushmita Das, Ashish Kumar, Kumar Abhishek, Sudha Verma, Abhishek Mandal, Rakesh K Singh, Pradeep Das

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Oxygen and immunity toInfection and immunity · 2025
    Review
  4. Article
  5. Lack of Hypoxia Inducible Factor-1α Influences on Macrophages Ability to Deal withJID innovations : skin science from molecules to population health · 2025
    Article
  6. Article
  7. Article
  8. Non-coding RNAs as emerging players inFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Comparative microRNA profiling ofFrontiers in cellular and infection microbiology · 2023
    Article
  15. Elucidating the role played by bone marrow in visceral leishmaniasis.Frontiers in cellular and infection microbiology · 2023
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Vinod KumarDivision of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.
Ajay KumarDivision of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.
Sushmita DasDepartment of Microbiology, All India Institute of Medical Sciences, Patna, India.
Ashish KumarDivision of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.
Kumar AbhishekDivision of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.
Sudha VermaDivision of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.
Abhishek MandalDivision of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.
Rakesh K SinghDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Pradeep DasDivision of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.
Rajendra Memorial Research Institute of Medical Sciences · INAll India Institute of Medical Sciences · INBanaras Hindu University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micro RNAs (miRNAs) have emerged as a critical regulator of several biological processes in both animals and plants. They have also been associated with regulation of immune responses in many human diseases during recent years. Visceral leishmaniasis (VL) is the most severe form of leishmaniasis, which is characterized by impairment of both innate and adaptive immune responses. In the present study, we observed that

Indexed as

cytokinesHIF-1αmacrophagesmiR-210NF-κBvisceral leishmaniasis

Identifiers

PMID29568285
PMCPMC5852103
OpenAlexW2790884145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.